UnVRap, a B2B VR SaaS solution for treating phobias, is exploring the feasibility of integrating a biofeedback sensor into VR headsets. The goal is to assess the technical, financial, and market viability of a sensor that measures brain activity without disturbing phobic patients. This project will involve researching current wearable health technologies, analyzing market trends, and evaluating the cost-effectiveness of developing such a device. The team will also explore potential challenges in integrating the sensor with existing VR headsets and ensure it aligns with UnVRap's mission of providing effective phobia treatment. The study will provide insights into whether this innovation can enhance UnVRap's offerings and meet market demands.

The project will culminate in a comprehensive feasibility report that includes:

- A technical assessment of current biofeedback sensor technologies.

- A financial analysis detailing potential costs and revenue projections.

- A market analysis identifying target demographics and competitors.

- Recommendations for next steps in the development process.

This report will guide UnVRap in deciding whether to pursue the integration of the biofeedback sensor into their VR solutions.